Wednesday, January 27, 2010

Updates on HSV

january's Eyeworld

N
ow that Zirgan (ganciclovir ophthalmic gel 0.15%) has been approved by the Food and Drug Administration (FDA) for acute herpetic keratitis, ophthalmologists may wonder how this will fit into their treatment options..“Zirgan is a welcome treatment for dendritic keratitis in the U.S. It’s a five-times-a-day gel drop and is as effective if not more effective than aciclovir. It’s also more comfortable and less toxic than Viroptic(1% trifluridine, GlaxoSmithKline, Middlesex, United Kingdom)...

No comments: